KO
Kura Oncology Inc
🇺🇸XNAS.KURAUnited StatesHealthcare
$11.32USDup +0.01 (+0.09%)OpenDelayed6:13 PM
Price$11.32+0.01 (+0.09%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US50127T1097
- CUSIP
- 50127T109
Company
- Employees
- 260
- Headquarters
- San Diego, United States
- Website
- https://kuraoncology.com
- CEO
- Dr. Troy Edward Wilson J.D., Ph.D.
Market
- Shares outstanding
- 89M
- Market cap
- $1.01B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $1.01B
- EPS LTM
- -$3.34calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -3.39calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $77.23M-7.27%down year on year
- Net income
- -$296.78M-50.52%down year on year
- Gross margin
- 94.13%-5.14%down year on year
- Free cash flow
- -$117.43M-195.58%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.